© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Top Medical News
Community Q&A: Ellen Mowry, MD, on the TREAT-MS Trial
October 27, 2021
By Matt Hoffman
The director of the Multiple Sclerosis Experimental Therapeutics Program at Johns Hopkins Medicine offered insight on the TREAT-MS trial to attendees of the CMSC 2021 annual meeting.
North American, European Registry Data Show Impact of COVID-19 in Multiple Sclerosis
October 27, 2021
By Abby Reinhard
Data further investigated the impact of how individual disease-modifying therapies affect outcomes for this patient population.
Inadequate Medical Information Available Regarding Cannabis Use in MS
October 27, 2021
By Marco Meglio
All told, 48% of patients with MS reported that their most common primary person for guidance on cannabis use in MS was themself or no one, followed by a dispensary professional and MS physician.
NeuroVoices: Ilya Kister, MD, on Understanding Long-Term Responses to Vaccines in MS
October 27, 2021
By Marco Meglio
The professor of neurology at the NYU Grossman School of Medicine provided his thoughts on the VIOLA study and the importance of monitoring cell response of post-vaccinated patients with MS on DMTs.
Induction vs Escalation for MS: Should Patients Be Started on High-Efficacy DMT?
October 26, 2021
By Matt Hoffman
In the presidential lecture series at CMSC 2021, Ellen M. Mowry, MD, called into question whether or not the induction treatment approach in multiple sclerosis does in fact present a higher chance of preventing long-term disability.
